Intrinsic Value of S&P & Nasdaq Contact Us

Eagle Pharmaceuticals, Inc. EGRX OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
72/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — EGRX

Eagle Pharmaceuticals, Inc. (EGRX) has a market capitalization of $1.1M and trades at $0.09. The 52-week range is 0.085-3.87.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 0, Earnings Per Share (EPS) of $2.76, annual revenue of $316.61M.

The stock has a beta of 0.31, operates in the Healthcare sector.

Trading Data
Current Price$0.09
52-Week Range0.085-3.87
Volume170
Avg Volume (30D)3.79K
Market Cap$1.1M
Beta (1Y)0.31
Company
IPO Date2014-02-12
Employees134
CEOMichael Graves
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS2697961082
CUSIP269796108
Income (Latest Year)
Revenue$316.61M
Gross Profit$221.67M
EBITDA$106.83M
Operating Income$80.96M
Net Income$35.64M
EPS$2.76
EPS Diluted$2.73
Shares Outstanding$12.93M
Balance Sheet (Latest Year)
Total Assets$406.16M
Current Assets$188.75M
Cash & ST Investments$55.32M
Total Liabilities$172.6M
Total Debt$67.79M
Net Debt$12.47M
Total Equity$233.56M
Debt / Equity0.29
Valuation Ratios
P/E Ratio0
P/S Ratio0
P/B Ratio0
EV/EBITDA (approx)0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message